Valuation : Theraclion

Market Cap 47.67M 55.32M 45.13M 40.91M 76.75M 5.29B 77.14M 536M 206M 2.69B 208M 203M 8.5B P/E 2024
-2.66x
P/E 2025 -6.33x
Enterprise Value 55.52M 64.44M 52.57M 47.65M 89.39M 6.16B 89.84M 624M 240M 3.13B 242M 237M 9.9B EV / Sales 2024
22.5x
EV / Sales 2025 55.4x
Free-Float
39.01%
Yield 2024 *
-
Yield 2025 -
1 day-4.96%
1 week-10.93%
Current month-13.07%
1 month+3.66%
3 months-11.89%
6 months+44.89%
Current year+8.31%
1 week 0.65
Extreme 0.649
0.75
1 month 0.62
Extreme 0.618
0.8
Current year 0.4
Extreme 0.402
0.93
1 year 0.4
Extreme 0.402
1.25
3 years 0.14
Extreme 0.1416
1.25
5 years 0.14
Extreme 0.1416
2.22
10 years 0.14
Extreme 0.1416
6.3
Manager TitleAgeSince
Chief Executive Officer - 24/05/2023
Director of Finance/CFO - -
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member - 22/06/2021
Director/Board Member - 28/01/2022
Director/Board Member - 29/06/2023
Date Insider Type Main position Quantity % Market Cap. Importance
26/8/26 Exercice

Director

266,139 0.3627%
Change 5-day change 1-year change 3-year change Capi.($)
-4.96%-10.93%-6.86%+6.54% 55.32M
+1.10%-0.65%+24.10%+18.43% 225B
-0.19%-3.62%+2.55%-20.00% 141B
+2.41%+0.67%-19.02%+22.09% 130B
-0.28%-10.08%-58.81%-21.22% 62.29B
-2.77%-6.15%+8.15%+12.69% 48.63B
-0.49%-1.97%-20.35%-15.53% 49.39B
+2.66%-2.61%+15.94%+29.91% 41.42B
+1.67%-0.25%+35.01%+55.09% 40.12B
-0.60%-4.41%-20.52%+44.06% 31.23B
Average -0.14%-4.17%-3.98%+13.20% 76.97B
Weighted average by Cap. +0.52%-2.50%+0.60%+9.84%

Financials

2024 2025
Net sales 830K 964K 786K 713K 1.34M 92.05M 1.34M 9.34M 3.59M 46.83M 3.62M 3.54M 148M 652K 757K 617K 560K 1.05M 72.29M 1.06M 7.33M 2.82M 36.78M 2.84M 2.78M 116M
Net income -5.76M -6.68M -5.45M -4.94M -9.27M -638M -9.32M -64.74M -24.9M -325M -25.09M -24.54M -1.03B -5.69M -6.6M -5.39M -4.88M -9.16M -631M -9.21M -63.99M -24.61M -321M -24.8M -24.26M -1.01B
Net Debt 3.41M 3.96M 3.23M 2.93M 5.49M 378M 5.52M 38.36M 14.75M 192M 14.87M 14.54M 608M 7.85M 9.11M 7.43M 6.74M 12.64M 871M 12.71M 88.3M 33.96M 443M 34.23M 33.47M 1.4B
Logo Theraclion
Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.
Employees
36
Date Price Change Volume
11/09/26 €0.6520 -4.96% 146,745
10/09/26 €0.6860 -2.00% 40,299
09/09/26 €0.7000 +2.19% 42,969
08/09/26 €0.6850 -1.30% 19,120
07/09/26 €0.6940 -5.19% 49,171

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALTHE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!